Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9181549 Conjugated antisense compounds and their use

Patent 9181549 was granted and assigned to Ionis Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 17 Oct, 2024

"update inverses"

edited on 17 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12116573 Targeting ligands for therapeutic compounds

0

Edits on 14 Aug, 2024

"update inverses"

edited on 14 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease

0

Edits on 25 Jul, 2024

"update inverses"

edited on 25 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

Edits on 27 Jun, 2024

"update inverses"

edited on 27 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12018260 Tunable Reversir™ compounds

0

Edits on 19 Jun, 2024

"update inverses"

edited on 19 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12013403 Compositions and methods for detection of SMN protein in a subject and treatment of a subject

0

Edits on 9 Feb, 2024

"update inverses"

edited on 9 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11891605 Reducing intron retention

0

Edits on 30 Jan, 2024

"update inverses"

edited on 30 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11879125 GalNAc compositions for improving siRNA bioavailability

0

Edits on 19 Jan, 2024

"update inverses"

edited on 19 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11873490 Antisense oligomers for treatment of conditions and diseases

0

Edits on 27 Dec, 2023

"update inverses"

edited on 27 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

0

Edits on 3 Dec, 2023

"Add patent abstract"

edited on 3 Dec, 2023

Edits made to:

Article (+168 characters)

Article

Patent abstract

Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.

Edits on 22 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 22 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=09181549

Edits on 23 May, 2023

"Remove leading 0 from patent number"

edited on 23 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09181549 Conjugated antisense compounds and their use US Patent 9181549 Conjugated antisense compounds and their use

Infobox

Patent Number

09181549

Patent Number

9181549

Edits on 17 Jun, 2022

"Entity importer update"

edited on 17 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09181549

Edits on 4 Jan, 2022

"Created via: Entity Importer"

created this topic on 4 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 09181549 Conjugated antisense compounds and their use

Infobox

Is a

Patent applicant

Ionis Pharmaceuticals

Current assignee

Ionis Pharmaceuticals

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09181549

Date of patent

November 10, 2015

Patent application number

14586751

Date Filed

December 30, 2014

Patent primary examiner

Traviss C Mcintosh, III

Find more entities like US Patent 9181549 Conjugated antisense compounds and their use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool